SPRED2 coordinates three signaling pathways to suppress liver cancer stemness
Liver cancer is the fifth most commonly diagnosed cancer and the second leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) accounts for 70-85% of primary liver cancers, and its five-year recurrence rate can reach 70-80%.
Read original article on The Medical News →Related news
-
T-cell research reveals paths to better vaccines for COVID-19 and beyond
-
New signaling pathway enhances blood stem cell transplantation outcomes
-
Insuficiência cardíaca: do diagnóstico ao tratamento | VEJA e Cuide-se
-
Cutting sugary drinks helps reduce childhood obesity, study finds
-
The 9 Best Amazon Bedsheets for a Luxurious Night’s Sleep
-
Despite the controversy, data centers could be attractive to struggling rural towns
-
Cyberbullying acts as an extension of in-person school violence
-
Masked high blood pressure linked to higher risk of falls in older adults